My Member
Message Center
trending topics
market reports
-
MEDICAL JAPAN 2025 OSAKA Returns to Showcase Global Innovations
2025-02-17
-
Visit MEDICAL JAPAN 2023 TOKYO and take full advantage of the business opportunities!
2023-09-01
-
US to distribute 400 million free N95 masks at CVS, Walgreens in COVID fight
2022-01-21
-
Ethiopia receives additional 2.2 mln doses of Chinese-donated COVID-19 vaccines
2022-01-21
-
Hong Kong researchers say they develop novel material able to kill COVID-19 virus
2022-01-14
-
10 million more Chinese doses on way for Kenya
2022-01-14
-
Sino-African ties on track for a brighter future
2022-01-07
-
Efforts urged to boost COVID-19 vaccine production capacity in poor countries
2022-01-07
-
UAE approves Sinopharm's new protein-based COVID-19 vaccine
2022-01-07
-
UAE approves Sinopharm's new protein-based COVID-19 vaccine
2022-01-07
-
China's daily output of COVID-19 vaccines reaches 5 million doses
BEIJING -- The daily output of Chinese COVID-19 vaccines has reached 5 million doses, a senior official said.
2021-03-26 -
China approves its fourth COVID-19 vaccine for emergency use
China approved a recombinant protein subunit vaccine against COVID-19 for emergency use on Wednesday, according to the vaccine's developer, the Institute of Microbiology of the Chinese Academy of Sciences.
2021-03-17 -
China's recombinant protein vaccine to aid global fight against COVID-19: Expert
BEIJING -- China's homegrown recombinant protein COVID-19 vaccine, recently approved for use in Uzbekistan, is expected to be another "powerful weapon" in fighting the global pandemic, a senior Chinese CDC official has said.
2021-03-10 -
China approves three TCM drugs to treat COVID-19
BEIJING -- China has approved the sale of three traditional Chinese medicine (TCM) drugs through a special approval procedure, offering more options for COVID-19 treatment, according to the National Medical Products Administration.
2021-03-05 -
New vaccine to 'provide 2-year protection'
An adenovirus vector vaccine against COVID-19 by CanSino Biologics is projected to provide protection for two years if a booster shot is administered, said a scientist who played a key role in the vaccine's development.
2021-03-03 -
Chinese jabs 'effective for virus variants'
China's COVID-19 vaccines are effective against the two major variants of the novel coronavirus that have been imported.
2021-02-24 -
Single-shot CanSino vaccine also stands out for being easier to store
The COVID-19 vaccine candidate manufactured by Chinese firm CanSino Biologics has an overall efficacy rate of 65.7 percent at preventing symptomatic cases and is 90.98 percent effective in preventing severe disease with a single injection.
2021-02-23 -
Countries lining up to obtain Sinovac COVID-19 vaccines
Countries, including Indonesia, the Philippines, Thailand and Nigeria, are cooperating with China in procuring or rolling out COVID-19 vaccines produced by the Chinese pharmaceutical company Sinovac, according to the South China Morning Post.
2021-01-19 -
Turkey approves China's Sinovac jab
ANKARA - Turkey on Wednesday approved the emergency use of a coronavirus jab developed by China's Sinovac, paving the way for a national vaccination drive that will start with healthcare workers.
2021-01-14 -
Internet hospital helps cure Tumxuk patients
People in Tumxuk, Xinjiang Uygur autonomous region, are enjoying more convenient medical treatment and a wider range of cultural choices thanks to ongoing support from Dongguan, Guangdong province.
2021-01-13